As the incidence of genetic disorders increases, there is a corresponding rise in the demand for molecular biology enzymes, kits, and reagents essential for conducting tests. These tools are vital for ...

ETH researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch ...

By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

Organoids were cultured from healthy donor iPSC sources and differentiated using the human iPSC-derived Cerebral Organoid ...

Researchers have created a novel imaging-technology combination that can capture gene activity in individual bacteria in ...

The manuscript addresses the 3D chromatin architecture in monocytes from patients with alcohol-associated hepatitis and its relationship to enhanced transcription of innate immune genes. While the ...

No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

Nuclera’s Key Account Manager shares how their eProtein Discovery system is propelling rapid recombinant protein optimization and its utilization in drug discovery.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties.

Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...

ExpressionEdits' Genetic Syntax Engine platform is designed to enhance gene expression within gene therapies by restoring introns.

This is an important and solid study that examines the role of TFAM, a protein that helps maintain mtDNA, in mtDNA mutator mice. The authors have demonstrated that TFAM's counteractive role in mtDNA ...